| INTRODUCTION
Hypoglycemia is a major complication in the management of type 1 diabetes (T1D) which when prolonged and severe can cause seizures and coma. Severe hypoglycemia (SH) is more likely to occur in patients who have reduced awareness of hypoglycemia. 1 Impaired awareness of hypoglycemia (IAH) is a syndrome in which the ability to detect the onset of hypoglycemia is diminished or absent. 2 Most hypoglycemic events are asymptomatic and undetected with increase in further hypoglycemia. 3 Recurrent episodes of hypoglycemia contribute to the development of defective symptomatic and counterregulatory hormone responses 4 leading to the syndrome of IAH and a substantially increased risk of SH. Therefore, it is vital to identify these at-risk patients to enable management strategies aimed to reduce hypoglycemia because prevention of hypoglycemia can restore awareness. 5 The identification of IAH is dependent on questionnaires that have been developed to answer this important clinical question. 1, 6, 7 IAH has been reported to affect approximately 25% of adults with T1D. [8] [9] [10] [11] Earlier studies of children and adolescents have similarly showed a significant proportion of youth to have IAH with a prevalence of 19% to 37%. [12] [13] [14] The pediatric and adult studies were all cross-sectional studies and used different questionnaires in a selective sample or clinic cohort. In contrast, this study aims to compare the prevalence of IAH measured using the same questionnaire at 2 time points in a population-based sample of children and adolescents older than 12 years with T1D. Although a recent crosssectional adult study concluded that IAH prevalence has not changed over the last 20 years, 10 a reduction in the rates of SH in T1D in the last decade raise the question as to whether there has been a reduction in the prevalence of IAH over a period of time. The novelty of this study is in its ability to examine the change in prevalence of IAH in a population-based cohort. The modified Clarke questionnaire was administered to children older than 12 years who filled them at their scheduled clinic visit.
| METHODS
Clarke developed an 8-question system designed to characterize the patient's exposure to episodes of moderate and SH and to also examine the glycemic threshold for, and symptomatic responses to hypoglycemia. 6 A modified version of Clarke's questionnaire (Table S1 , Supporting Information) has previously been used at our centre. 13, 14, 17 This was designed to be simple to administer to children. This com- attempted by the participant, they were excluded from analysis.
| Statistical analysis
Prevalence of IAH was calculated for each cohort (2002 and 2015) and compared using a z-test. Clinical characteristics of the study groups were compared using the Mann-Whitney U test (median AE 
| RESULTS
The modified Clarke questionnaire was administered to 413 participants in 2002; of these 390 had complete data. In 2015, the questionnaire was administered to 444 participants and of these, data were complete in 402.
| Clinical characteristics
The clinical characteristics of the 2 cohorts are demonstrated in 
| Impaired awareness of hypoglycemia
As shown in Table 1 b 2002: BD (twice a day) insulin regimen comprised isophane human insulin and regular/short acting insulin before breakfast and dinner while MDI (multiple daily insulin) comprised regular/short acting insulin at breakfast, lunch, and dinner with isophane human insulin at dinner.
c 2015: BD insulin regimen comprised isophane human insulin and short acting insulin (aspart or lispro) prebreakfast and detemir with short acting insulin predinner. MDI comprised fixed/flexible insulin therapy with short acting insulin before breakfast, lunch, and dinner with glargine at bed-time.
*P < .05 is statistically significant. Age at diagnosis (y) 9.1 (6.4-11.6) 8.0 (5.0-11.4) .007* 8.8 (5.8-11.7) 9.5 (5.0-11.0) .461
Duration of diabetes (y) 5.4 (1.9-9.6) 7.2 (4.2-10.1) .006* 6.5 (3.4-9.9) 6.2 (3.1-9.5) .750
HbA1c at last visit (%) 8.3 (7.4-9.1) 7.9 (7.0-8. to analyze the predictors of SH; although patients on BD insulin are at highest risk as seen in Table 3 .
The strength of this study is in its ability to compare a demographically similar clinic population using the same questionnaire across 2 time points providing an insight into the change in prevalence of IAH over time. Although this study demonstrates a reduction in IAH with improvement in management, IAH is still prevalent in a substantial minority of the clinic population and it is vital to identify these patients in clinical practice as this group is at a significantly higher risk of severe hypoglycemic events. Identification of these individuals is an important component of T1D management. a Values are in n and (%).
